Andreas Halvorsen - Viking Global Investors
Holding/activity history for Edgewise Therapeutics Inc (EWTX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2025 Q1 | 490,035 | 0.03 | Reduce 60.00% | 0.07 | $22.00 | $10,780,770 | SEC |
| 2024 Q4 | 1,224,986 | 0.11 | Reduce 17.29% | 0.02 | $26.70 | $32,707,126 | SEC |
| 2024 Q3 | 1,481,146 | 0.14 | $26.69 | $39,531,787 | SEC | ||
| 2024 Q2 | 1,481,146 | 0.10 | Reduce 55.64% | 0.13 | $18.01 | $26,675,439 | SEC |
| 2024 Q1 | 3,339,146 | 0.23 | Reduce 45.79% | 0.11 | $18.24 | $60,906,023 | SEC |
| 2023 Q4 | 6,159,146 | 0.25 | $10.94 | $67,381,057 | SEC | ||
| 2023 Q3 | 6,159,146 | 0.14 | Add 3.63% | <0.01 | $5.73 | $35,291,907 | SEC |
| 2023 Q2 | 5,943,261 | 0.19 | Add 21.07% | 0.03 | $7.75 | $46,060,273 | SEC |
| 2023 Q1 | 4,909,146 | 0.15 | Add 11.34% | 0.02 | $6.67 | $32,744,004 | SEC |
| 2022 Q4 | 4,409,146 | 0.20 | $8.94 | $39,417,765 | SEC | ||
| 2022 Q3 | 4,409,146 | 0.20 | Add 61.67% | 0.08 | $9.84 | $43,386,000 | SEC |
| 2022 Q2 | 2,727,249 | 0.10 | $7.96 | $21,709,000 | SEC | ||
| 2022 Q1 | 2,727,249 | 0.11 | $9.70 | $26,454,000 | SEC | ||
| 2021 Q4 | 2,727,249 | 0.12 | $15.28 | $41,672,000 | SEC | ||
| 2021 Q3 | 2,727,249 | 0.13 | $16.60 | $45,272,000 | SEC | ||
| 2021 Q2 | 2,727,249 | 0.18 | Reduce 18.64% | 0.06 | $21.33 | $58,172,000 | SEC |
| 2021 Q1 | 3,352,249 | 0.32 | Buy | 0.32 | $32.50 | $108,948,000 | SEC |